DIN 02527715 — POTELIGEO 4 MG
POTELIGEO is a solution of Mogamulizumab marketed by KYOWA KIRIN, INC.. The full Mogamulizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02527715
- Brand name
- POTELIGEO
- Active ingredient
- Mogamulizumab
- Strength
- 4 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- KYOWA KIRIN, INC.
- Health Canada status
- MARKETED
- Drug class
- Anti-CCR4 monoclonal antibody (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.